SCHEDULE 13D

Company

ADMA BIOLOGICS, INC.

Filed

February 22, 2012

Accession Number

0000950142-12-000456

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →